Study guide
1.6 Hematologic, Endocrine, Connective Tissue & Other Systemic Disorders
NCC Inpatient Obstetric Nursing RNC-OB
Track your progress as you read
Finished sections get a check mark.
1 Chapter 0: Introduction & How to Use This Guide
0.1 About the RNC-OB Credential & Exam Blueprint 0.2 How to Use This Study Guide & Clinical Learning Methodology
2 Chapter 1: Pregnancy Complications — Maternal Medical Conditions
1.1 Hypertensive Disorders of Pregnancy 1.2 HELLP Syndrome & Hepatic Disorders of Pregnancy 1.3 Diabetes Mellitus in Pregnancy 1.4 Maternal Cardiac and Respiratory Disorders 1.5 Infectious Diseases in Inpatient Obstetrics 1.6 Hematologic, Endocrine, Connective Tissue & Other Systemic Disorders
3 Chapter 2: Pregnancy Complications — Preterm Labor, Multiple Gestation, Placental & Fetal Disorders
2.1 Psychosocial Disorders, Substance Use & Environmental Exposures 2.2 Preterm Labor: Assessment, Tocolysis & Neuroprotection 2.3 Multiple Gestation: Placentation, Chorionicity & Complications 2.4 Placental Disorders: Previa, Abruption, Vasa Previa & PAS 2.5 Fetal Growth Disorders & Amniotic Fluid Complications
4 Chapter 3: Antenatal Fetal Assessment & Surveillance
3.1 Antenatal Testing Methods & Indications for Fetal Surveillance 3.2 Nonstress Test (NST), Contraction Stress Test (CST) & Biophysical Profile (BPP) 3.3 Diagnostic Prenatal Procedures (Amniocentesis, CVS, PUBS, cfDNA & Ultrasound) 3.4 Fetal Oxygenation Physiology & Acid-Base Regulation 3.5 Umbilical Cord Blood Gas Collection & Clinical Interpretation
5 Chapter 4: Fetal Assessment & Electronic Fetal Monitoring (EFM)
4.1 NICHD Electronic Fetal Monitoring Terminology & Baseline Features 4.2 FHR Decelerations, Acceleration Patterns & Uterine Activity 4.3 The NICHD Three-Tier Fetal Heart Rate Classification System 4.4 Intrauterine Resuscitation & Clinical Action Protocols 4.5 Fetal Arrhythmias, Dysrhythmias & Artifact Differentiation
6 Chapter 5: Labor & Birth Physiology — Mechanics, Cardinal Movements, Stages & Support
5.1 Physiology of Labor & Uterine Mechanics 5.2 Pelvic Anatomy, Fetal Lie, Presentation & Cardinal Movements of Labor 5.3 Stages of Labor, Cervical Dilatation Dynamics & Progression Guidelines 5.4 Intrapartum Admission Assessment, Obstetric Triage & Membrane Rupture Evaluation 5.5 Labor Support, Non-Pharmacologic Pain Management & Physiologic Birth Practices
7 Chapter 6: Labor & Birth Interventions — Cervical Ripening, Induction, Pain Management & Anesthesia
6.1 Bishop Scoring, Pre-Induction Cervical Ripening & Mechanical Methods 6.2 Oxytocin Administration, Titration Protocols & Uterine Tachysystole Management 6.3 Nonpharmacologic Comfort & Labor Pain Management Strategies 6.4 Systemic Opioid Analgesia & Inhaled Nitrous Oxide 6.5 Neuraxial Analgesia, Spinal/Epidural Complications & General Anesthesia
8 Chapter 7: Labor & Birth — Operative Deliveries, TOLAC/VBAC & Special Intrapartum Procedures
7.1 External Cephalic Version (ECV) & Malpresentation Management 7.2 Operative Vaginal Delivery: Vacuum Extraction & Forceps-Assisted Birth 7.3 Cesarean Delivery: Surgical Indications, Intraoperative Management & PACU Recovery 7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC) 7.5 Special Intrapartum Procedures: Amniotomy, Amnioinfusion, Cervical Ripening & Labor Augmentation
9 Chapter 8: Obstetric Emergencies & Critical Care
8.1 Shoulder Dystocia Management & HELPERR Protocol 8.2 Umbilical Cord Prolapse & Feto-Vascular Emergencies 8.3 Uterine Rupture & Acute Uterine Inversion 8.4 Amniotic Fluid Embolism (Anaphylactoid Syndrome of Pregnancy) 8.5 Intraamniotic Infection (Chorioamnionitis) & Maternal Sepsis
10 Chapter 9: Postpartum Physiology & Immediate Recovery Care
9.1 Postpartum Physiologic Changes & Maternal Systemic Adaptations 9.2 Fourth Stage of Labor & Immediate Recovery Care 9.3 Routine Postpartum Nursing Assessment & Clinical Care (BUBBLE-HE) 9.4 Rh Isoimmunization, Alloimmunization & Postpartum Immunizations 9.5 Postpartum Discharge Teaching, Warning Signs & Maternal Safety
11 Chapter 10: Postpartum Adaptation, Hemorrhage & Clinical Complications
10.1 Postpartum Hemorrhage: Definition, Risk Stratification, 4 Ts, QBL & Pharmacotherapy 10.2 Postpartum Infections: Endometritis, Wound Infections, Sepsis & Postpartum Pyrexia 10.3 Thromboembolic Disorders: DVT, Pulmonary Embolism & Septic Pelvic Thrombophlebitis 10.4 Perinatal Mood & Anxiety Disorders: Postpartum Blues, PPD, Anxiety & Postpartum Psychosis 10.5 Lactation Physiology, Breastfeeding Complications, Engorgement & Medication Safety
12 Chapter 11: Newborn Care, Transition & Clinical Assessment
11.1 Neonatal Physiologic Transition & Cardiorespiratory Adaptation 11.2 Immediate Newborn Care, Apgar Scoring & Delivery Room Stabilization 11.3 Newborn Thermoregulation & Pathophysiology of Cold Stress 11.4 Gestational Age & Neonatal Growth Assessment 11.5 Comprehensive Newborn Head-to-Toe Examination & Normal Variants
13 Chapter 12: Newborn Complications, Resuscitation & High-Acuity Management
12.1 Neonatal Resuscitation Program (NRP 8th Edition) & Delivery Room Resuscitation 12.2 Neonatal Glucose Homeostasis, Hypoglycemia Screening & Clinical Management 12.3 Neonatal Hyperbilirubinemia, Bilirubin Metabolism & Phototherapy Protocols 12.4 Neonatal Respiratory Distress: TTN, RDS, Meconium Aspiration & Persistent Pulmonary Hypertension (PPHN) 12.5 Neonatal Sepsis, Congenital Infections & Neonatal Abstinence Syndrome (NAS/NOWS)
14 Chapter 13: Professional Practice, Legal-Ethical Frameworks, Patient Safety & Quality Improvement
13.1 Legal Aspects of Perinatal Nursing & High-Risk Documentation Standards 13.2 Ethical Principles in Perinatal Care & Maternal-Fetal Conflicts 13.3 Quality Improvement, Perinatal Safety Initiatives & AIM Bundles 13.4 Patient Safety Culture, Team Communication & Clinical Escalation 13.5 Evidence-Based Practice, Research Utilization & Perinatal Guidelines
1.6 Hematologic, Endocrine, Connective Tissue & Other Systemic Disorders
Key Takeaways Explain This Topic AI
Physiologic anemia of pregnancy is caused by a 45-50% expansion of plasma volume exceeding a 20-30% increase in RBC mass (hemodilution), defining anemia as hemoglobin <11.0 g/dL (Hct <33%) in 1st/3rd trimesters and <10.5 g/dL (Hct <32%) in 2nd trimester; iron deficiency anemia is confirmed by serum ferritin <30 ng/mL.
Sickle Cell Disease (HbSS/HbSC) crises are precipitated by hypoxia, acidosis, dehydration, and hypothermia; acute management requires aggressive IV hydration, supplemental oxygen (target SpO2 ≥95%), multimodal opioid analgesia, and exchange transfusion for acute chest syndrome (avoid empiric iron therapy).
Disseminated Intravascular Coagulation (DIC) is an acute consumptive coagulopathy characterized by platelet count <100,000/μL, fibrinogen <200 mg/dL (critically <100 mg/dL), prolonged PT/INR and aPTT, elevated D-dimer, and schistocytes; component replacement targets fibrinogen >150-200 mg/dL (Cryoprecipitate 1-2 pools) and platelets >50,000/μL.
Maternal Systemic Lupus Erythematosus (SLE) with positive anti-SSA/Ro and anti-SSB/La antibodies carries a 2-5% risk of fetal complete congenital heart block (manifesting as fixed fetal bradycardia 50-80 bpm starting at 16-26 weeks gestation), requiring serial fetal echocardiography; maternal lupus flare is distinguished from preeclampsia by low serum complement (C3/C4) and active urinary sediment.
Antithyroid pharmacotherapy requires Propylthiouracil (PTU) during the first trimester to avoid methimazole embryopathy (aplasia cutis, choanal atresia), followed by Methimazole in the second and third trimesters to prevent PTU-induced maternal fulminant hepatotoxicity.
Last updated: August 2026
- Hematologic Disorders in Pregnancy
- Physiologic Anemia vs. Pathologic Iron Deficiency
During pregnancy, maternal plasma volume expands by 45% to 50% , whereas red blood cell (RBC) erythrocyte volume increases by only 20% to 30% . This disproportionate expansion creates a state of physiologic hemodilution (physiologic anemia of pregnancy) .
Diagnostic Cutoffs for Anemia (CDC / ACOG):
- First Trimester: Hemoglobin (Hgb) <11.0 g/dL (Hematocrit [Hct] <33%)
- Second Trimester: Hgb <10.5 g/dL (Hct <32%)
- Third Trimester: Hgb <11.0 g/dL (Hct <33%)
- Postpartum: Hgb <10.0 g/dL (Hct <30%)
Iron Deficiency Anemia (IDA): Represents 75% of all non-physiologic gestational anemias. A serum ferritin level <30 ng/mL is the single most sensitive and specific diagnostic test (microcytic, hypochromic indices with low MCV <80 fL appear later). Oral elemental iron (60–120 mg/day) paired with Vitamin C on an empty stomach is first-line; IV iron sucrose or ferric carboxymaltose is indicated for oral intolerance, severe anemia (Hgb <8–9 g/dL) late in gestation, or malabsorptive states.
Sickle Cell Disease (HbSS, HbSC, HbS-Beta Thalassemia)
Sickle cell disease is an autosomal recessive hemoglobinopathy in which an abnormal beta-globin chain causes hemoglobin S polymerisation, erythrocyte sickling, vascular occlusion, and chronic hemolytic anemia under conditions of hypoxemia, dehydration, acidosis, cold exposure, or infection .
Maternal and Perinatal Complications: High incidence of maternal acute vaso-occlusive pain crises, acute chest syndrome (leading cause of death), preeclampsia (30%), placental infarction, fetal growth restriction (FGR), and stillbirth.
Inpatient Crisis Management Protocol:
Aggressive IV Hydration: Continuous crystalloid infusion (150–200 mL/hr) to reduce blood viscosity and reverse intravascular sickling.
Oxygen Therapy: Maintain continuous pulse oximetry; administer supplemental oxygen to keep SpO2 >= 95% .
Multimodal Analgesia: Prompt, scheduled or patient-controlled IV opioids (morphine, hydromorphone) for acute pain episodes.
Avoid Empiric Iron Therapy: Patients with sickle cell disease receive multiple lifetime transfusions and are at high risk for hemosiderosis (iron overload) . Iron supplementation is strictly withheld unless true iron deficiency is verified by low ferritin.
Acute Chest Syndrome (ACS): Defined by new pulmonary infiltrates on chest X-ray accompanied by fever, chest pain, tachypnea, cough, or hypoxemia. Requires immediate ICU transfer, broad-spectrum IV antibiotics, oxygen, and emergent automated red blood cell exchange transfusion (erythrocytapheresis) to reduce HbS concentration to <30%. +-------------------------------------------------------------------------------------------------------------------+
| DIFFERENTIAL DIAGNOSIS OF THROMBOCYTOPENIA IN PREGNANCY |
+-------------------------------------------------------------------------------------------------------------------+
- Disorder Platelet Count Nadir Onset Timing Clinical Features & Pathophysiology
- ----------------------- -------------------- ------------ -----------------------------------
Gestational Thrombocytopenia 70,000 - 149,000/μL Mid-2nd to 3rd Trimester - 75% of all cases; benign hemodilution & clearance
- (GT) (Rarely <70,000/μL) - Asymptomatic; NO fetal thrombocytopenia
- Resolves spontaneously by 2-12 wk postpartum
-------------------------------------------------------------------------------------------------------------------
- Immune Thrombocytopenia Often <50,000/μL Pre-pregnancy or - Anti-platelet IgG antibodies destroy platelets
- (ITP) (Can be <20,000/μL) 1st / Early 2nd Trim - Maternal petechiae, purpura, mucosal bleeding
- Fetal thrombocytopenia risk (IgG crosses placenta)
- Rx: Oral Prednisone (1 mg/kg) or IVIG (1 g/kg)
-------------------------------------------------------------------------------------------------------------------
- Preeclampsia with Severe <100,000/μL After 20 weeks - Endothelial injury, platelet activation/consumption
- Features / HELLP (Can drop <20,000) - Associated with severe HTN, transaminitis, hemolysis
-------------------------------------------------------------------------------------------------------------------
Disseminated Intravascular Rapidly falling Acute / Catastrophic - Systemic consumptive coagulopathy
Coagulation (DIC) (often <50,000/μL) Intrapartum/Postpartum - Prolonged PT/PTT, Fibrinogen <200, severe bleeding
+-------------------------------------------------------------------------------------------------------------------+
Disseminated Intravascular Coagulation (DIC) in Obstetrics
Obstetric DIC is an acute, life-threatening consumptive coagulopathy triggered by the massive release of tissue factor (thromboplastin) into the maternal circulation or by widespread endothelial disruption. Thrombin generation accelerates uncontrollably, causing systemic microvascular fibrin deposition, consumption of clotting factors and platelets, and secondary hyperfibrinolysis.
Primary Obstetric Triggers:
- Placental Abruption (most common cause in pregnancy due to retroplacental tissue factor release)
- Severe Postpartum Hemorrhage (uterine atony, trauma, surgical bleeding)
- Amniotic Fluid Embolism (AFE / Anaphylactoid Syndrome of Pregnancy)
- Severe Pre-eclampsia and HELLP Syndrome
- Intra-amniotic Infection / Sepsis (gram-negative endotoxins)
- Retained Dead Fetus Syndrome (prolonged retention >4–6 weeks)
Diagnostic Laboratory Profile and Transfusion Component Therapy +-------------------------------------------------------------------------------------------------------------------+
| OBSTETRIC DIC: LABORATORY TARGETS & COMPONENT THERAPY |
+-------------------------------------------------------------------------------------------------------------------+
- Laboratory Test Normal Third Trimester Value DIC Diagnostic Threshold Component Therapy / Target
- -------------- ---------------------------- ------------------------ --------------------------
- Fibrinogen 350 - 600 mg/dL (Hyperfibrin) <200 mg/dL (Critical: <100) CRYOPRECIPITATE (1-2 pools)
- Target: >150 - 200 mg/dL
-------------------------------------------------------------------------------------------------------------------
- Platelet Count 150,000 - 400,000/μL <100,000/μL PLATELETS (1 apheresis unit)
- Target: >50,000/μL
-------------------------------------------------------------------------------------------------------------------
- Prothrombin Time (PT) 10 - 12 seconds Prolonged (>1.5x control) FRESH FROZEN PLASMA (FFP)
- aPTT 25 - 35 seconds Prolonged (>1.5x control) Target: Normal PT/INR & aPTT
-------------------------------------------------------------------------------------------------------------------
D-Dimer Mildly elevated in pregnancy Markedly Elevated (>5-10x) Reflects active fibrinolysis
-------------------------------------------------------------------------------------------------------------------
- Hemoglobin / Hct 11 - 14 g/dL / 33 - 42% Acute drop PACKED RED BLOOD CELLS (PRBCs)
- Target: Hgb >8.0 g/dL
+-------------------------------------------------------------------------------------------------------------------+
Cryoprecipitate: The primary source of concentrated fibrinogen (contains 200–250 mg fibrinogen per unit, plus Factor VIII, von Willebrand factor, and Factor XIII). A 10-unit pool raises maternal fibrinogen by approximately 50 to 100 mg/dL .
Tranexamic Acid (TXA): Antifibrinolytic agent administered as 1 g IV over 10 minutes within 3 hours of bleeding onset for postpartum hemorrhage.
- Maternal Endocrine Disorders
- Thyroid Disease in Pregnancy
Physiologic Adaptations: Human chorionic gonadotropin (hCG) shares structural homology with TSH, weakly stimulating the thyroid gland in the first trimester, causing a transient decrease in TSH. Estrogen increases Thyroid-Binding Globulin (TBG) 2-fold, increasing total T3 and T4, while free T4 remains in the normal reference range.
Hypothyroidism (Hashimoto's Thyroiditis):
Clinical Impact: Inadequate maternal thyroid hormone during the first trimester impairs fetal neurodevelopment, causing reduced offspring IQ, preeclampsia, abruption, and low birth weight.
Treatment: Levothyroxine (Synthroid): Dosing must be increased by 25% to 30% immediately upon pregnancy confirmation. Target TSH: <2.5 mIU/L in 1st trimester , <3.0 mIU/L in 2nd/3rd trimesters . Monitor TSH every 4 to 6 weeks.
Hyperthyroidism (Graves' Disease):
Antithyroid Drug Selection: Propylthiouracil (PTU) is used during the first trimester because Methimazole is associated with specific embryopathies (aplasia cutis congenita, choanal atresia, and esophageal atresia). Methimazole is substituted during the second and third trimesters to avoid PTU-associated maternal fulminant hepatic necrosis.
Thyroid Storm: Life-threatening hypermetabolic emergency triggered by labor, infection, or cesarean birth. Symptoms: hyperthermia (>103°F / 39.4°C), tachycardia (>140 bpm), atrial fibrillation, agitation, and congestive heart failure. Treatment: 1) High-dose PTU (600–800 mg PO/NG); 2) Saturated Solution of Potassium Iodide (SSKI) given 1 hour AFTER PTU; 3) IV Dexamethasone (2 mg q6h) to block T4 to T3 conversion; 4) IV Propranolol for beta-blockade; 5) Supportive cooling.
Autoimmune Connective Tissue Disorders: Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus (SLE) is an autoimmune disorder characterized by antinuclear antibody (ANA) production, immune complex deposition, and multiorgan inflammation.
Lupus Flare vs. Preeclampsia Differentiation
Both disorders present in late pregnancy with hypertension, proteinuria, and renal decline. Differentiating features include:
Lupus Nephritis Flare: Decreased serum complement levels ( low C3 and C4 ), elevated anti-dsDNA antibody titers, and active urinary sediment (dysmorphic red blood cells and RBC casts).
Preeclampsia: Serum complement levels (C3/C4) remain normal or elevated , anti-dsDNA is negative, and urine sediment shows proteinuria without cellular casts.
Neonatal Lupus and Congenital Complete Heart Block
Maternal IgG autoantibodies directed against ribonucleoprotein antigens—specifically anti-SSA/Ro and anti-SSB/La —cross the placenta starting at 16 weeks of gestation. These antibodies bind to fetal cardiac conduction tissue, triggering autoimmune myocarditis, inflammatory destruction, and irreversible fibrosis of the fetal atrioventricular (AV) node.
Clinical Manifestation: Irreversible Congenital Third-Degree (Complete) Heart Block developing between 16 and 26 weeks of gestation. The fetal heart rate baseline becomes permanently bradycardic at 50 to 80 beats per minute , unresponsive to movement or contractions.
Inpatient Intrapartum Monitoring: Electronic fetal heart rate monitoring will demonstrate persistent fixed bradycardia without variability. Immediate delivery room pediatric cardiology resuscitation with external/temporary transvenous pacing capability is mandatory.
- Hyperemesis Gravidarum and Bariatric Surgery Considerations
- Hyperemesis Gravidarum (HG)
Definition: Severe, intractable nausea and vomiting leading to >5% pre-pregnancy weight loss , dehydration, ketonuria, and electrolyte derangements (hypokalemic, hypochloremic metabolic alkalosis).
Wernicke's Encephalopathy Prevention: Prolonged vomiting and carbohydrate metabolism deplete maternal thiamine (Vitamin B1). Thiamine (100 mg IV) MUST ALWAYS BE ADMINISTERED BEFORE any dextrose-containing IV solutions to prevent acute Wernicke's encephalopathy (confusion, ataxia, nystagmus/ophthalmoplegia, and permanent memory loss).
Post-Bariatric Surgery in Inpatient Obstetrics
Roux-en-Y Gastric Bypass / Malabsorptive Procedures: High risk of maternal micronutrient deficiencies (Vitamin B12, folate, iron, Vitamin D, calcium, copper, and fat-soluble vitamins).
Dumping Syndrome: Ingestion of concentrated simple carbohydrates triggers rapid fluid shifts into the bowel (early dumping) and severe reactive hyperinsulinemic hypoglycemia (late dumping). The standard 50g oral Glucose Loading Test (GLT) is strictly avoided in post-gastric bypass patients due to severe dumping; gestational diabetes screening is performed using home fasting and 1- to 2-hour postprandial capillary glucose logs for 1 to 2 weeks.
Internal Hernia: Acute abdominal pain in a pregnant post-bariatric patient is an acute surgical emergency representing internal bowel herniation behind mesenteric surgical defects, which can rapidly progress to strangulation and bowel necrosis.